Immunodeficiency-Related Malignant Neoplasm

Immunodeficiency-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: AIDS Malignancy Consortium
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00310128	Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma	withdrawn	Phase 2	0	AIDS Malignancy ConsortiumNETWORK	0	Feb 3, 2016	clinicaltrials
NCT02137564	Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma	withdrawn	Phase 2	0	AIDS Malignancy ConsortiumNETWORK	0	Jul 23, 2015